Crinetics Pharmaceuticals (CRNX)
(Delayed Data from NSDQ)
$48.00 USD
-1.42 (-2.87%)
Updated May 10, 2024 04:00 PM ET
After-Market: $48.00 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.83 | 0.00% |
Earnings Summary
For their last quarter, Crinetics Pharmaceuticals (CRNX) reported earnings of -$0.93 per share, missing the Zacks Consensus Estimate of -$0.84 per share. This reflects a negative earnings surprise of 10.71%. Look out for CRNX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.83 per share, reflecting a year-over-year increase of 11.7%.
Earnings History
Price & Consensus
Zacks News for CRNX
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
CRNX: What are Zacks experts saying now?
Zacks Private Portfolio Services